OPEC Monthly Report: OPEC expects U.S. shale oil production to remain flat in 2026 compared with last year as producers maintain capital discipline.

Overseas 1. Goldman Sachs: Still expects oil supply in the Middle East to remain uninterrupted. 2. Goldman Sachs: Still expects gold to reach $3,700 by the end of the year. 3. Citi: Israel's actions complicate Trump's efforts to lower oil prices. 4. ANZ: Powell may continue to be patient and wait and see. 5. OCBC: The situation in the Middle East is unlikely to cause a big wave unless it triggers an oil shock. 6. RBC: The Middle East crisis has escalated, and attacks on energy facilities are worrying. 7. Swissquote: Risks in the Strait of Hormuz still support oil prices. Domestic 1. CICC: More optimistic about opportunities in non-US regions in the second half of the year. 2. CITIC Construction Investment: The volatility center of the A-share market is expected to gradually move up in the second half of the year. 3. CITIC Securities: Geopolitical disturbances have increased uncertainty and oil prices may fluctuate sharply. 4. CITIC Securities: The conflict in the Middle East may become an inducement for a structural shift in the market. 5. CITIC Securities: The intensity and duration of the conflict between Israel and Iran may significantly exceed the mutual attacks last year. 6. CITIC Securities: The liquidity of Hong Kong stocks continues to improve. If there is a fluctuation with overseas, it is a good opportunity to increase positions. 7. CITIC Securities: It is expected that the US, UK and Japanese central banks will maintain the policy interest rate unchanged at their interest rate meetings this week. 8. Huatai Securities: The conflict between Iran and Israel has expanded, and oil prices have entered a high volatility phase. 9. Huatai Securities: Q3 volatility is high, and Hong Kong stocks such as dividends and essential consumption can still be used as bottom-line configurations.

Hong Kong stocks opened, the Hang Seng Index opened down 0.42%, the Sci-Tech Index opened down 0.61%. WuXi Biologics (02269.HK) fell 3.57% as the company's major shareholder placed existing shares.